Aziz Mottiwala
Chief Commercial Officer, OPIANT PHARMACEUTICALS, INC.
Companies
- RxSight, Inc.Board member Jul 24, 2026 to now1
- RxSight, Inc.Chief executive officer Jul 24, 2026 to now1
- RxSight, Inc.President Jul 24, 2026 to now1
- Tarsus Pharmaceuticals, Inc.Chief Commercial Officer Oct 15, 2020 to now2
- OPIANT PHARMACEUTICALS, INC.Chief Commercial Officer Sep 20, 2019 to Sep 20, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS61,480 shares4$4.3M at $69.64Mar 19, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 19, 2026Sold 4,440 shares at $67.00 of Tarsus Pharmaceuticals, Inc.4
- Mar 18, 2026Sold 4,330 shares at $68.71 of Tarsus Pharmaceuticals, Inc.4
- Mar 17, 2026Sold 4,286 shares at $69.42 of Tarsus Pharmaceuticals, Inc.4
- Mar 15, 2026Exercised options 26,482 shares of Tarsus Pharmaceuticals, Inc.5
- Jun 9, 2025Sold 17,500 shares at $43.76 of Tarsus Pharmaceuticals, Inc.6
- Mar 20, 2025Sold 3,365 shares at $50.11 of Tarsus Pharmaceuticals, Inc.7
- Mar 19, 2025Sold 3,557 shares at $47.40 of Tarsus Pharmaceuticals, Inc.7
- Mar 18, 2025Sold 3,643 shares at $46.29 of Tarsus Pharmaceuticals, Inc.7
- Mar 15, 2025Exercised options 20,957 shares of Tarsus Pharmaceuticals, Inc.8
- Mar 18, 2024Sold 4,766 shares at $30.60 of Tarsus Pharmaceuticals, Inc.9
- Mar 15, 2024Exercised options 12,938 shares of Tarsus Pharmaceuticals, Inc.9
- Jul 19, 2023Sold 2,400 shares at $20.05 of Tarsus Pharmaceuticals, Inc.10
- Jun 8, 2023Sold 100 shares at $20.00 of Tarsus Pharmaceuticals, Inc.11
- Jun 7, 2023Sold 2,500 shares at $19.34 of Tarsus Pharmaceuticals, Inc.12
- Jun 6, 2023Sold 2,143 shares at $18.61 of Tarsus Pharmaceuticals, Inc.12
- Mar 23, 2023Sold 372 shares at $12.15 of Tarsus Pharmaceuticals, Inc.13
- Mar 22, 2023Sold 357 shares at $12.64 of Tarsus Pharmaceuticals, Inc.13
- Mar 21, 2023Sold 349 shares at $12.89 of Tarsus Pharmaceuticals, Inc.13
- Mar 20, 2023Sold 358 shares at $12.61 of Tarsus Pharmaceuticals, Inc.14
- Mar 17, 2023Sold 339 shares at $13.28 of Tarsus Pharmaceuticals, Inc.14
- Mar 16, 2023Sold 336 shares at $13.43 of Tarsus Pharmaceuticals, Inc.15
- Mar 15, 2023Exercised options 4,790 shares of Tarsus Pharmaceuticals, Inc.15
- Nov 15, 2022Sold 6,857 shares at $17.72 of Tarsus Pharmaceuticals, Inc.16
- Aug 24, 2022Exercised options 772 shares at $0.45 of Tarsus Pharmaceuticals, Inc.17
- Aug 24, 2022Exercised options 4,416 shares at $10.99 of Tarsus Pharmaceuticals, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRxSight, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 17, 2026
- 6SEC EDGARForm 4 filed Jun 11, 2025
- 7SEC EDGARForm 4 filed Mar 20, 2025
- 8SEC EDGARForm 4 filed Mar 18, 2025
- 9SEC EDGARForm 4 filed Mar 19, 2024
- 10SEC EDGARForm 4 filed Jul 21, 2023
- 11SEC EDGARForm 4 filed Jun 12, 2023
- 12SEC EDGARForm 4 filed Jun 8, 2023
- 13SEC EDGARForm 4 filed Mar 23, 2023
- 14SEC EDGARForm 4 filed Mar 21, 2023
- 15SEC EDGARForm 4 filed Mar 17, 2023
- 16SEC EDGARForm 4 filed Nov 17, 2022
- 17SEC EDGARForm 4 filed Aug 26, 2022